Ignite Creation Date:
2025-12-24 @ 9:47 PM
Ignite Modification Date:
2026-01-01 @ 10:10 AM
Study NCT ID:
NCT01987232
Status:
COMPLETED
Last Update Posted:
2017-08-28
First Post:
2013-11-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung Cancer
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-11-05
Start Date Type:
None
Primary Completion Date:
2016-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-04
Completion Date Type:
ACTUAL
First Submit Date:
2013-11-06
First Submit QC Date:
None
Study First Post Date:
2013-11-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-07-26
Results First Submit QC Date:
None
Results First Post Date:
2017-08-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-26
Last Update Post Date:
2017-08-28
Last Update Post Date Type:
ACTUAL